BeOne Medicines (ONC) CEO sells 64,628 ADS after exercising options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BeOne Medicines Ltd. director and CEO John Oyler exercised options to acquire 64,628 American Depositary Shares (ADS), representing 840,164 Ordinary Shares, at $119.96 per ADS, and then sold 64,628 ADS in multiple open-market transactions at weighted-average prices, with execution prices ranging from $304.96 to $315.18 per ADS, pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2026. Following these transactions, he directly holds 5,445,917 Ordinary Shares, and the filing also lists substantial indirect holdings in various trusts and Oyler Investment LLC, for which beneficial ownership is disclaimed, as well as 9,545,000 Ordinary Shares held for his benefit in a Roth IRA.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 64,628 shares ($20,163,907)
Net Sell
17 txns
Insider
OYLER JOHN
Role
Chief Executive Officer
Sold
64,628 shs ($20.16M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (Right to Buy) | 840,164 | $0.00 | -- |
| Exercise | American Depositary Shares | 64,628 | $119.96 | $7.75M |
| Sale | American Depositary Shares | 1,440 | $305.1985 | $439K |
| Sale | American Depositary Shares | 597 | $306.9642 | $183K |
| Sale | American Depositary Shares | 680 | $309.0541 | $210K |
| Sale | American Depositary Shares | 4,833 | $310.3694 | $1.50M |
| Sale | American Depositary Shares | 5,543 | $311.423 | $1.73M |
| Sale | American Depositary Shares | 35,829 | $312.1748 | $11.18M |
| Sale | American Depositary Shares | 14,915 | $313.1879 | $4.67M |
| Sale | American Depositary Shares | 740 | $314.3198 | $233K |
| Sale | American Depositary Shares | 51 | $315.0624 | $16K |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 441,870 shares (Direct);
American Depositary Shares — 64,628 shares (Direct);
Ordinary Shares — 5,445,917 shares (Direct);
Ordinary Shares — 481,533 shares (Indirect, See Footnote)
Footnotes (1)
- These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership. These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interests are owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account. These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership. Each American Depositary Share represents 13 Ordinary Shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.96 to $305.605, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.61 to $307.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.77 to $309.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.78 to $310.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.78 to $311.77, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.78 to $312.77, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.78 to $313.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.83 to $314.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.88 to $315.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events.
Key Figures
ADS sold: 64,628 American Depositary Shares
Options exercised (Ordinary Shares): 840,164 Ordinary Shares
ADS exercise price: $119.9600 per ADS
+4 more
7 metrics
ADS sold
64,628 American Depositary Shares
Total ADS sold by John Oyler on 2026-07-17 across multiple transactions
Options exercised (Ordinary Shares)
840,164 Ordinary Shares
Shares underlying options exercised and converted into 64,628 ADS
ADS exercise price
$119.9600 per ADS
Price per ADS for the non-derivative acquisition related to the option exercise
Option exercise price
$9.2300 per Ordinary Share
Exercise price of Share Options (represented in Ordinary Shares)
Direct Ordinary Shares held
5,445,917 Ordinary Shares
Direct BeOne Medicines holdings reported for John Oyler after transactions
Roth IRA holdings
9,545,000 Ordinary Shares
Ordinary Shares held for Oyler’s benefit in a Roth IRA PENSCO trust account
Unexercised Share Options
441,870 options
Share Options remaining outstanding after partial exercise, expiring June 4, 2029
Key Terms
American Depositary Share, Rule 10b5-1 trading plan, grantor retained annuity trust, weighted average price, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
grantor retained annuity trust financial
"These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee..."
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
weighted average price financial
"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did BeOne Medicines (ONC) CEO John Oyler report on July 17, 2026?
John Oyler reported exercising options into 64,628 American Depositary Shares and then selling the same 64,628 ADS in multiple open-market transactions. All reported sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 10, 2026.
What options did John Oyler exercise in this BeOne Medicines (ONC) Form 4 filing?
Oyler exercised 840,164 Share Options into 840,164 Ordinary Shares (64,628 ADS) at an exercise price of $9.23 per Ordinary Share. After this partial exercise, 441,870 Share Options remain outstanding, expiring on June 4, 2029.
Was John Oyler’s BeOne Medicines (ONC) ADS selling activity discretionary or under a plan?
The ADS sales were conducted under a Rule 10b5-1 trading plan adopted by John Oyler on March 10, 2026. Such plans pre-schedule trades, so the timing of these transactions is governed by the plan’s terms rather than day-to-day trading decisions.